Robert Shumaker
Impact in
- Obstetrics and Gynecology top 2%
- Endometrial and Cervical Cancer Treatments
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Plant Toxicity and Pharmacological Properties 6
- Co-authors
- Corina E. Dutcus (4 shared papers)Matthew H. Taylor (3 shared papers)Daniel E. Stepan (3 shared papers)Vicky Makker (3 shared papers)Drew Rasco (2 shared papers)Jane Wu (2 shared papers)Carol Aghajanian (2 shared papers)Allen Lee Cohn (2 shared papers)
- Journals
- AAPG Bulletin (5 papers)Cancer Chemotherapy and Pharmacology (2 papers)Investigational New Drugs (2 papers)The Journal of Clinical Pharmacology (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Robert Shumaker
40 papers receiving 1.8k citations
Robert Shumaker's Hit Papers
Peers
Comparison fields: 5 of 98
- Obstetrics and Gynecology 276
- Oncology 642
- Hepatology 153
- Reproductive Medicine 148
- Pharmacology 117
Countries citing papers authored by Robert Shumaker
This map shows the geographic impact of Robert Shumaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Shumaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Shumaker more than expected).
Fields of papers citing papers by Robert Shumaker
This network shows the impact of papers produced by Robert Shumaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Shumaker. The network helps show where Robert Shumaker may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Shumaker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer Hit paper breakdown → | 2020 | 366 |
| 2 | Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial Hit paper breakdown → | 2019 | 363 |
| 3 | Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid Tumors Hit paper breakdown → | 2020 | 313 |
| 4 | 2014 | 66 | |
| 5 | 2016 | 65 | |
| 6 | 2017 | 60 | |
| 7 | 2015 | 59 | |
| 8 | 2014 | 51 | |
| 9 | 2014 | 49 | |
| 10 | 2014 | 44 | |
| 11 | 1976 | 43 | |
| 12 | 1994 | 40 | |
| 13 | 1994 | 40 | |
| 14 | 1992 | 39 | |
| 15 | 2012 | 37 | |
| 16 | 2000 | 35 | |
| 17 | 2014 | 32 | |
| 18 | 1992 | 25 | |
| 19 | 2018 | 18 | |
| 20 | 1988 | 17 |
About Robert Shumaker
Robert Shumaker is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Mechanics of Materials, Pharmacology and Oncology, having authored 41 papers that have together received 1.9k indexed citations. Recurring topics across this work include Hydrocarbon exploration and reservoir analysis (7 papers), Plant Toxicity and Pharmacological Properties (6 papers), Geological and Geochemical Analysis (4 papers), Atmospheric and Environmental Gas Dynamics (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Thyroid Cancer Diagnosis and Treatment (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). The work is most often cited by research in Obstetrics and Gynecology (276 citations), Oncology (642 citations), Hepatology (153 citations), Reproductive Medicine (148 citations) and Pharmacology (117 citations). Robert Shumaker has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Corina E. Dutcus, Matthew H. Taylor, Daniel E. Stepan, Vicky Makker, Drew Rasco, Jane Wu, Carol Aghajanian, Allen Lee Cohn, James W. Mier and Marcia S. Brose. Their work appears in journals such as AAPG Bulletin, Cancer Chemotherapy and Pharmacology, Investigational New Drugs, The Journal of Clinical Pharmacology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.